How many institutions own GNTA stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own GNTA shares is 12, representing 10.74% of the company's common stock.

Who are the major shareholders selling Genenta Science S.p.A. stock?

NATIONAL BANK OF CANADA /FI/, in the last quarter, reduced its stake in GNTA by -11.07% restricting it's holding to 2.67 thousand shares of worth nearly $3.82K. EVERSOURCE WEALTH ADVISORS, LLC also lessened -100% of the GNTA shares from its portfolio, reducing its holding to 0 shares of worth -. UBS GROUP AG also shunned GNTA shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Investors who are buying GNTA stock?

As per its latest 13F filing, GAMMA INVESTING LLC increased its stake in GNTA by 100% in the last quarter. The institutional holder raised its holding to 2.83 thousand shares having worth more than $4.21K. ALYESKA INVESTMENT GROUP, L.P. also added 100% more shares of GNTA to its portfolio, raising its holding to 219.84 thousand shares of worth $327.56K. NORGES BANK also increased its GNTA shares holding by 100% which brought its holding to 226.18 thousand shares worth $337.01K.

GNTA's major insiders: who are they?

The insider with the most stakes in GNTA is ROSENWALD LINDSAY A MD , 10 percent owner at the company. Additionally, GNTA stock is highly held by VP, Sales & Marketing Sanders Walter Lloyd and director Driscoll Martin J among others.

Did an insider recently sell GNTA stock?

Company executives, directors, and other insiders own 39.15% percent of Genenta Science S.p.A.'s stock. Within the last six months, there have been 0 transaction(s) in which GNTA insiders have sold stock, totaling 0 shares. Insiders that have sold shares include ROSENWALD LINDSAY A MD.

Which insider recently purchased GNTA stock?

There have been 0 transaction(s) during the past 6-months in which Genenta Science S.p.A. insiders have bought stock, totalling 0 shares

How much of GNTA does insiders own?

Around 0 Genenta Science S.p.A. shares are held by insiders, which represents about 39.15% of GNTA stock.

Who is the insider with the largest stake?

GNTA 10 percent owner, ROSENWALD LINDSAY A MD holds the largest portfolio of the company's shares. GNTA shares owned by ROSENWALD total nearly 184.87 thousand.

Which institution holds the most shares in GNTA?

GAMMA INVESTING LLC is the largest institutional owner in GNTA which holds 2.83 thousand shares worth $4.21K or 0.02% of the total GNTA shares outstanding followed by ALYESKA INVESTMENT GROUP, L.P. with ownership of 219.84 thousand shares representing 1.17% of the GNTA ownership. NORGES BANK is the third largest stakeholder with 226.18 thousand shares or 1.21% of the ownership worth more than $337.01K.

Is Genenta Science S.p.A. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the GNTA is concerned, it is a stock which is not optionable.

Is there a short position on GNTA's shares?

Number of GNTA shares short is 6.66K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding GNTA shares are there?

As of today, 18.29M shares of GNTA are outstanding.

Is there many float in GNTA stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, GNTA has 11.22M shares in float.

GNTA short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for GNTA is 0.29.

Genenta Science SpA (GNTA) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares0.04

Short Percent Of Float0.06

Shares Outstanding18.29M

Shares Float11.22M

Shares Short6.66K

Short Ratio0.29

0.06%

Short % of Float

0.04%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

39.15% Percentage of Shares held by All Insiders

10.74% Percentage of Shares held by All Institutions

17.65% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 10.74% of GNTA shares are held by financial institutions. GAMMA INVESTING LLC is the top corporate investor, holding 2.83K shares valued at $4.21K. A 0.02% stake in Genenta Science S.p.A. is owned by the company. ALYESKA INVESTMENT GROUP, L.P. owns 219.84K shares valued at $327.56K, which translates its holding of 1.17% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Dec 31, 2025	GAMMA INVESTING LLC	0.02%	2.83K	4.21K	2.83K	+100.00%
Dec 31, 2025	ALYESKA INVESTMENT GROUP, L.P.	1.17%	219.84K	327.56K	219.84K	+100.00%
Dec 31, 2025	NORGES BANK	1.21%	226.18K	337.01K	226.18K	+100.00%
Dec 31, 2025	ALLIANZ SE	1.25%	234.05K	348.74K	0	0
Dec 31, 2025		0.09%	17.78K	26.49K	17.78K	+100.00%
Dec 31, 2025	NATIONAL BANK OF CANADA /FI/	0.01%	2.67K	3.82K	-332	-11.07%
Dec 31, 2025	FARTHER FINANCE ADVISORS, LLC	0%	3	4	3	+100.00%
Dec 31, 2025	UBS GROUP AG	0.02%	3.42K	5.09K	3.42K	+100.00%
Dec 31, 2025	WEISS ASSET MANAGEMENT LP	1.72%	322.03K	479.82K	322.03K	+100.00%
Dec 31, 2025	GHISALLO CAPITAL MANAGEMENT LLC	1.73%	323.8K	482.46K	323.8K	+100.00%
Dec 31, 2025	CITADEL ADVISORS LLC	3.49%	655.16K	976.19K	642.68K	+5,147.19%
Dec 31, 2025	MORGAN STANLEY	0.24%	45.9K	68.39K	43.7K	+1,986.36%
Dec 31, 2025	ALGEBRIS (UK) LTD	0.53%	100K	149.07K	0	0
Dec 31, 2025	CARTESIAN GROWTH CORP	1.07%	200.29K	298.43K	0	0
Sep 30, 2025	EVERSOURCE WEALTH ADVISORS, LLC	0%	0	-	-982	-100.00%
Sep 30, 2025	MORGAN STANLEY	0.01%	2.2K	7K	200	+10.00%
Sep 30, 2025	ALLIANZ SE	1.28%	234.05K	744.28K	0	0
Sep 30, 2025	CARTESIAN GROWTH CORP	1.1%	200.29K	636.92K	0	0
Sep 30, 2025	CITADEL ADVISORS LLC	0.07%	12.49K	40.95K	12.49K	+100.00%
Sep 30, 2025	NATIONAL BANK OF CANADA /FI/	0.02%	3K	9.54K	3K	+100.00%
Sep 30, 2025	ALGEBRIS (UK) LTD	0.55%	100K	327.75K	0	0
Jun 30, 2025	CARTESIAN GROWTH CORP	1.1%	200.29K	791.14K	0	0
Jun 30, 2025	UBS GROUP AG	0%	0	-	-91	-100.00%
Jun 30, 2025	ALLIANZ SE	1.28%	234.05K	712.68K	500	+0.21%
Jun 30, 2025	ALGEBRIS (UK) LTD	0.55%	100K	309.51K	0	0
Jun 30, 2025	EVERSOURCE WEALTH ADVISORS, LLC	0.01%	982	2.99K	982	+100.00%
Jun 30, 2025	MORGAN STANLEY	0.01%	2K	6.09K	-1.4K	-41.18%
Mar 31, 2025	CITADEL ADVISORS LLC	0%	0	-	-11.17K	-100.00%
Mar 31, 2025	ALGEBRIS (UK) LTD	0.55%	100K	368.45K	55K	+122.22%
Mar 31, 2025	CARTESIAN GROWTH CORP	1.1%	200.29K	795.14K	0	0
Mar 31, 2025	MORGAN STANLEY	0.02%	3.4K	13.5K	3.4K	+100.00%
Mar 31, 2025	ALLIANZ SE	1.28%	233.55K	927.19K	130.3K	+126.20%
Mar 31, 2025	UBS GROUP AG	0%	91	361	91	+100.00%
Mar 31, 2024	ALGEBRIS (UK) LTD	0.25%	45K	145.97K	0	0
Mar 31, 2024	BANK JULIUS BAER & CO. LTD, ZURICH	2.12%	385.31K	1.44M	0	0
Mar 31, 2024	MORGAN STANLEY	0%	500	1.75K	0	0
Mar 31, 2024	UBS GROUP AG	0%	41	144	-2.26K	-98.22%
Dec 31, 2023	ALGEBRIS (UK) LTD	0.25%	45K	185.89K	0	0
Dec 31, 2023	MORGAN STANLEY	0%	500	2.48K	0	0
Dec 31, 2023	UBS GROUP AG	0.01%	2.3K	11.39K	2.3K	+100.00%
Dec 31, 2023	BANK JULIUS BAER & CO. LTD, ZURICH	2.26%	412.55K	1.88M	0	0
Sep 30, 2023	BANK JULIUS BAER & CO. LTD, ZURICH	2.26%	412.55K	2.06M	0	0
Sep 30, 2023	UBS GROUP AG	0%	0	-	-700	-100.00%
Sep 30, 2023	MORGAN STANLEY	0%	500	2.58K	0	0
Sep 30, 2023	ALGEBRIS (UK) LTD	0.25%	45K	225.45K	0	0

Insiders

Among the GNTA insiders holding of 39.15% of the stake in company, ROSENWALD LINDSAY A MD, 10 percent owner, holds the largest shares of 184.87K. SANDERS WALTER LLOYD, VP, Sales & Marketing, is the second largest GNTA insider with ownership of 30.63K shares. DRISCOLL MARTIN J, director, stands third with possession of 15K shares of that stake.

Insiders	Designation	Shares Held
ROSENWALD LINDSAY A MD	10 percent owner	184.87K
SANDERS WALTER LLOYD	VP, Sales & Marketing	30.63K
DRISCOLL MARTIN J	director	15K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Nov 15, 2006	SANDERS WALTER LLOYD	PURCHASE	0.75	25K	18.75K	30.63K
Jun 23, 2006	SANDERS WALTER LLOYD	PURCHASE	1.63	56	91.28	5.63K
Jun 15, 2006	SANDERS WALTER LLOYD	PURCHASE	1.51	322	486.22	5.32K
May 12, 2006	DRISCOLL MARTIN J	PURCHASE	1.46	15K	21.9K	15K
May 05, 2004	ROSENWALD LINDSAY A MD	SALE	4.95	40.8K	201.96K	184.87K
May 04, 2004	ROSENWALD LINDSAY A MD	SALE	4.92	273.9K	1.35M	184.87K
May 03, 2004	ROSENWALD LINDSAY A MD	SALE	5.05	119.4K	602.97K	184.87K
Mar 23, 2004	ROSENWALD LINDSAY A MD	PURCHASE	9.42	5K	47.1K	17.85M
Mar 16, 2004	ROSENWALD LINDSAY A MD	PURCHASE	10.29	5K	51.45K	17.85M
Oct 20, 2003	ROSENWALD LINDSAY A MD	PURCHASE	10.07	5K	50.35K	17.96M
Sep 10, 2003	ROSENWALD LINDSAY A MD	PURCHASE	15.68	5K	78.4K	21.48M

GNTA Stock Ownership Breakdown